Therapeutic renal neuromodulation for treating dyspnea and associated systems and methods
US10292754B2 · kind B2 · utility
1Cited by
93References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 16, 2011 |
| Grant date | May 21, 2019 |
| Priority date | — |
| Expiry date | Aug 13, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2018/00613
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods for treating dyspnea with therapeutic renal neuromodulation and associated system and methods are disclosed herein. One aspect of the present technology, for example, is directed to methods that block, reduce, and/or inhibit renal sympathetic nerve activity to achieve a reduction in central sympathetic tone. Renal sympathetic nerve activity may be altered or modulated along the afferent and/or efferent pathway. The achieved reduction in central sympathetic tone may carry therapeutic benefits for patients with dyspnea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.